Some physicians using social media to give advice to patients aren't revealing drug industry ties or other conflicts of interest, a U.S. researcher says. Matthew DeCamp, a postdoctoral fellow in the Johns Hopkins University School of Medicine's Division of General Internal Medicine, says without such information -- standard practice when publishing in medical journals and recommended in one-on-one contacts with patients -- consumers are left in the dark. "As physicians and patients increasingly interact online, the standards of appropriate behavior become really unclear," DeCamp, who also holds a fellowship at the Johns Hopkins Berman Institute of Bioethics, said. Part of the problem, he said, is that some prominent medical societies have failed to lay out comprehensive guidelines for physicians on when and how to disclose a conflict of interest when using social media. "In light of norms of disclosure accepted throughout medicine, it's surprising that major medical guidelines fail to adequately address this issue," DeCamp said in a commentary published in the Journal of General Internal Medicine. While use of social media has the potential to improve patient care and trust by increasing patient access to information, DeCamp said, vigorous online "boundaries" are needed not only to assure privacy and confidentiality but also to protect patients from misinformation and biased advice.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor